Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.

Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.

Publication date: May 06, 2019

Considerable progress has been made during the past 20 years towards elucidating the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in skin cancer. In 1999, the original notion that PPARβ/δ was involved with epithelial cell function was postulated based on a correlation between PPARβ/δ expression and the induction of messenger RNAs encoding proteins that mediate terminal differentiation in keratinocytes. Subsequent studies definitively revealed that PPARβ/δ could induce terminal differentiation and inhibit proliferation of keratinocytes. Molecular mechanisms have since been discovered to explain how this nuclear receptor can be targeted for preventing and treating skin cancer. This includes the regulation of terminal differentiation, mitotic signaling, endoplasmic reticulum stress, and cellular senescence. Interestingly, the effects of activating PPARβ/δ can preferentially target keratinocytes with genetic mutations associated with skin cancer. This review provides the history and current understanding of how PPARβ/δ can be targeted for both nonmelanoma skin cancer and melanoma and postulates how future approaches that modulate PPARβ/δ signaling may be developed for the prevention and treatment of these diseases.

Concepts Keywords
Cellular Senescence Selective PPAR modulator
Correlation Nuclear receptor
Endoplasmic Reticulum Peroxisome proliferator-activated receptor
Epithelial Proteins
Genetic Mutations Cell biology
Keratinocytes Intracellular receptors
Melanoma Branches of biology
Mitotic Transcription factors
Nuclear Receptor Nonmelanoma skin melanoma
Skin Cancer


Type Source Name
pathway BSID Cell Cycle
pathway BSID Cell cycle
pathway BSID Melanoma
disease DOID melanoma
disease MESH melanoma
pathway BSID Cellular Senescence
disease MESH endoplasmic reticulum stress
disease DOID skin cancer
disease MESH skin cancer
pathway BSID Peroxisome


Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *